Repligen CorporationRGENNASDAQ
Loading
EBITDA Margin Over TimeStable
Percentile Rank36
3Y CAGR-13.7%
5Y CAGR-3.7%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-13.7%/yr
vs +12.6%/yr prior
5Y CAGR
-3.7%/yr
Recent deceleration
Acceleration
-26.3pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
202522.26%+75.9%
202412.65%-45.0%
202322.98%-33.6%
202234.60%+14.1%
202130.31%+12.8%
202026.87%+29.0%
201920.84%-3.2%
201821.53%+25.9%
201717.09%-27.2%
201623.48%-